Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Imaging of human lymph nodes using optical coherence tomography: potential for staging cancer.

McLaughlin RA, Scolaro L, Robbins P, Hamza S, Saunders C, Sampson DD.

Cancer Res. 2010 Apr 1;70(7):2579-84. doi: 10.1158/0008-5472.CAN-09-4062. Epub 2010 Mar 16.

2.

Mapping tissue optical attenuation to identify cancer using optical coherence tomography.

McLaughlin RA, Scolaro L, Robbins P, Saunders C, Jacques SL, Sampson DD.

Med Image Comput Comput Assist Interv. 2009;12(Pt 2):657-64.

PMID:
20426168
3.

Optical coherence tomography: the intraoperative assessment of lymph nodes in breast cancer.

Nguyen FT, Zysk AM, Chaney EJ, Adie SG, Kotynek JG, Oliphant UJ, Bellafiore FJ, Rowland KM, Johnson PA, Boppart SA.

IEEE Eng Med Biol Mag. 2010 Mar-Apr;29(2):63-70. doi: 10.1109/MEMB.2009.935722.

4.

Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.

Altinyollar H, Kapucuoglu N, Pak I, Berberoglu U.

J Exp Clin Cancer Res. 2000 Jun;19(2):141-4.

PMID:
10965808
5.

Sentinel node biopsy in ductal carcinoma in situ patients.

Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS.

Ann Surg Oncol. 2000 Jan-Feb;7(1):15-20.

PMID:
10674443
6.

Sentinel lymphadenectomy for breast cancer in a community managed care setting.

Guenther JM, Krishnamoorthy M, Tan LR.

Cancer J Sci Am. 1997 Nov-Dec;3(6):336-40.

PMID:
9403045
7.

Optical biopsy of lymph node morphology using optical coherence tomography.

Luo W, Nguyen FT, Zysk AM, Ralston TS, Brockenbrough J, Marks DL, Oldenburg AL, Boppart SA.

Technol Cancer Res Treat. 2005 Oct;4(5):539-48.

PMID:
16173824
8.

Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.

Okamoto T, Yamazaki K, Kanbe M, Kodama H, Omi Y, Kawamata A, Suzuki R, Igari Y, Tanaka R, Iihara M, Ito Y, Sawada T, Nishikawa T, Maki M, Kusakabe K, Mitsuhashi N, Obara T.

Breast Cancer. 2005;12(3):203-10.

9.

In vitro diagnosis of axillary lymph node metastases in breast cancer by spectrum analysis of radio frequency echo signals.

Tateishi T, Machi J, Feleppa EJ, Oishi R, Jucha J, Yanagihara E, McCarthy LJ, Noritomi T, Shirouzu K.

Ultrasound Med Biol. 1998 Oct;24(8):1151-9.

PMID:
9833584
10.

Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.

Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH, Reintgen DS.

Am Surg. 1999 Jun;65(6):500-5; discussion 505-6.

PMID:
10366202
11.

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.

Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA.

Ann Surg Oncol. 2007 Oct;14(10):2946-52. Epub 2007 May 19.

PMID:
17514407
12.

Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study.

Rehman S, Sardi A, Spiegler E, Colandrea J, Frishberg D.

Md Med J. 1999 May-Jun;48(3):105-10.

PMID:
10394225
13.

Ex vivo MRI of axillary lymph nodes in breast cancer.

Luciani A, Pigneur F, Ghozali F, Dao TH, Cunin P, Meyblum E, De Baecque-Fontaine C, Alamdari A, Maison P, Deux JF, Lagrange JL, Lantieri L, Rahmouni A.

Eur J Radiol. 2009 Jan;69(1):59-66. doi: 10.1016/j.ejrad.2008.07.040. Epub 2008 Dec 27.

PMID:
19112002
14.

Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.

Ponzone R, Cont NT, Maggiorotto F, Cassina E, Mininanni P, Biglia N, Sismondi P.

J Clin Oncol. 2009 Nov 20;27(33):5547-51. doi: 10.1200/JCO.2009.22.1846. Epub 2009 Oct 13.

15.

The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?

Wong JS, O'Neill A, Recht A, Schnitt SJ, Connolly JL, Silver B, Harris JR.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):133-7.

PMID:
10924982
16.

Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.

Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA.

Am J Surg Pathol. 2000 Sep;24(9):1266-72.

PMID:
10976701
17.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
18.

Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.

Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M.

Acta Oncol. 2008;47(2):232-8.

PMID:
17924207
20.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk